美国癌症联合委员会第 8 版肝胆管癌分期系统对肝门周围胆管癌的预后预测:与第 7 版相比,改善有限。

Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Cancer Res Treat. 2020 Jul;52(3):886-895. doi: 10.4143/crt.2020.023. Epub 2020 Mar 12.

Abstract

PURPOSE

This study was conducted to evaluate the prognostic values of the 7th and 8th American Joint Committee on Cancer (AJCC) staging systems for patients with resected perihilar cholangiocarcinoma (PHCC).

MATERIALS AND METHODS

A total of 348 patients who underwent major hepatectomy for PHCC between 2008 and 2015 were identified from a single center. Overall survival (OS) was estimated using the Kaplan-Meier method and compared across stage groups with the log-rank test. The concordance index was used to evaluate the prognostic predictability of the 8th AJCC staging system compared with that of the 7th.

RESULTS

In the 8th edition, the stratification of each group of T classification improved compared to that in the 7th, as the survival rate of T4 decreased (T2, 31.2%; T3, 13.9%; T4, 15.1%; T1-T2, p=0.260; T2-T3, p=0.001; T3-T4, p=0.996). Both editions showed significant survival differences between each N category, except between N1 and N2 (p=0.063) in 7th edition. Differences of point estimates between the 8th and 7th T and N classification and overall stages were +0.028, +0.006, and +0.039, respectively (T, p=0.005; N, p=0.115; overall stage, p=0.005). In multivariable analysis, posthepatectomy liver failure, T category, N category, distant metastasis, histologic differentiation, intraoperative transfusion, and resection margin status were associated with OS.

CONCLUSION

The prognostic predictability of 8th AJCC staging for PHCC improved slightly, with statistical significance, compared to the 7th edition, but its overall performance is still unsatisfactory.

摘要

目的

本研究旨在评估第 7 版和第 8 版美国癌症联合委员会(AJCC)分期系统对可切除肝门部胆管癌(PHCC)患者的预后价值。

材料和方法

从单一中心确定了 2008 年至 2015 年间接受 PHCC 根治性肝切除术的 348 例患者。采用 Kaplan-Meier 法估计总生存期(OS),并采用对数秩检验比较各分期组之间的 OS。采用一致性指数评估第 8 版 AJCC 分期系统与第 7 版相比的预后预测能力。

结果

在第 8 版中,与第 7 版相比,T 分类的每个组的分层得到了改善,因为 T4 患者的生存率降低(T2,31.2%;T3,13.9%;T4,15.1%;T1-T2,p=0.260;T2-T3,p=0.001;T3-T4,p=0.996)。两个版本在每个 N 类别之间均显示出显著的生存差异,除了第 7 版中 N1 和 N2 之间(p=0.063)。第 8 版和第 7 版 T 和 N 分类以及总分期之间的点估计差异分别为+0.028、+0.006 和+0.039(T,p=0.005;N,p=0.115;总分期,p=0.005)。多变量分析显示,术后肝衰竭、T 分类、N 分类、远处转移、组织学分化、术中输血和切缘状态与 OS 相关。

结论

与第 7 版相比,第 8 版 AJCC 分期对 PHCC 的预后预测能力略有改善,且具有统计学意义,但总体性能仍不理想。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e687/7373861/aea7342e258b/crt-2020-023f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索